Todd Kenney

Todd Kenney is an accomplished biopharmaceutical executive with extensive experience in quality assurance and compliance across multiple organizations. Currently serving as Senior Vice President at Xenon Pharmaceuticals Inc. since November 2022, Todd has previously held significant roles including Vice President of Quality at Dicerna Pharmaceuticals, Vice President and Head of Quality at Unum Therapeutics, and Head of Quality at Neon Therapeutics. With a solid background at Akebia Therapeutics and Genzyme, Todd has demonstrated expertise in developing and implementing comprehensive quality management systems, overseeing quality operations for clinical-stage biotech firms, and managing quality assurance functions for commercial products. Todd holds a Bachelor of Applied Science degree in Biology from Saint Michael's College.